X
First patient dosed in trial of Allergan/Editas’ CRISPR blindness drug
https://pharmaphorum.com/news/first-patient-dosed-in-trial-of-allergan-editas-crispr-blindness-drug/
blindness
Raising awareness of LHON for Rare Disease Day 2018
As Rare Disease Day approaches on 28 February, Santhera has created an infographic explaining the signs and symptoms of the rare disease Leber’s hereditary optic neuropathy (LHON), a progressive eye disease that results in blindness.
‘Bionic eye’ receives FDA fast-track review designation
Review of Second Sight’s Orion will now be streamlined.
Shedding light on LHON: the rare blindness affecting young adults
LHON is a frequently misdiagnosed condition that needs faster diagnosis.
Australian biotech gets $18 million for ‘bionic eye’
Company gains $18 million in funding.
Artificial vision device helps blind ‘read’ faces
The Orcam My Eye improves performance in daily tasks such as reading and writing.